Comparable stake leader
FMR LLC
SEC ownership of Jazz Pharmaceuticals plc
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001232524.
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
05 Aug 2026
- Public ticker
- JAZZ on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
FMR LLC
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
FMR LLC
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
05 Aug 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001232524
- Issuer location
- Dublin
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of Jazz Pharmaceuticals plc (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
BlackRock, Inc.
Comparable rows
50/50
Latest evidence
05 Aug 2026
13D/G
13F
3/4/5
Lead comparable stake: 7.4%
13D/G row: FMR LLC
Showing 1-8 of 50 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 7.4%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
7.4%
VANGUARD CAPITAL MANAGEMENT LLC
5%
Seamus Mulligan
2%
Bruce C. Cozadd
0.57%
Renee D. Gala
0.23%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13D/G
13F
Company
|
7.4%
|
$1,141,606,780
4,675,459 shares
|
$0 | 30 Jun 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
13D/G
Company · Vanguard Capital Management
|
5%
from 13D/G
|
$657,763,761
2,729,650 shares
|
— | 30 Jun 2026 |
| Seamus Mulligan |
3/4/5
Director
|
2%
|
$309,948,626
1,286,254 shares
|
— | 05 Aug 2026 |
| Bruce C. Cozadd |
3/4/5
Director
|
0.57%
|
$87,300,298
362,287 shares
|
-$26,418,149 | 05 Aug 2026 |
| Renee D. Gala |
3/4/5
President & CEO
|
0.23%
|
$27,858,597
147,361 shares
|
— | 30 Jun 2026 |
| Robert Iannone |
3/4/5
EVP, Global Head of R&D & CMO
|
0.13%
|
$16,089,478
85,107 shares
|
-$1,204,573 | 30 Jun 2026 |
| Philip L. Johnson |
3/4/5
EVP & Chief Financial Officer
|
0.09%
|
$10,668,280
56,431 shares
|
— | 30 Jun 2026 |
| Neena M. Patil |
3/4/5
EVP & Chief Legal Officer
|
0.08%
|
$9,239,062
48,871 shares
|
-$11,211,147 | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$48,004,865.
Buys
$0
Insiders: 0
Sells
$48,004,865
Insiders: 10
Net
-$48,004,865
Shares: -254,503
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 254,503
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 28,456 | $0 | $6,824,807 | -$6,824,807 |
| 3-6 | 0 | 90,756 | $0 | $17,662,953 | -$17,662,953 |
| 6-9 | 0 | 84,398 | $0 | $14,957,486 | -$14,957,486 |
| 9-12 | 0 | 50,893 | $0 | $8,559,618 | -$8,559,618 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-20 of 28 reporting-owner rows connected to Jazz Pharmaceuticals plc. Open a relationship link for the CIK-to-CIK filing trail.
Rows
28
Largest Forms 3/4/5 holder
Seamus Mulligan
Net 12M change
-$48,004,865
Latest report
05 Aug 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Seamus Mulligan | Director | $309,948,626 | Median | 05 Aug 2026 | ||
| Bruce C. Cozadd | Director | $87,300,298 | -$26,418,149 | -23% | Median | 05 Aug 2026 |
| Renee D. Gala | President & CEO | $27,858,597 | Mixed | 30 Jun 2026 | ||
| Robert Iannone | EVP, Global Head of R&D & CMO | $16,089,478 | -$1,204,573 | -7% | Mixed | 30 Jun 2026 |
| Samantha J. Pearce | EVP, Chief Commercial Officer | $11,357,157 | -$1,625,977 | -13% | Median | 05 Aug 2026 |
| Philip L. Johnson | EVP & Chief Financial Officer | $10,668,280 | Mixed | 30 Jun 2026 | ||
| Neena M. Patil | EVP & Chief Legal Officer | $9,239,062 | -$11,211,147 | -55% | Mixed | 30 Jun 2026 |
| Daniel N. Swisher Jr. | President and COO | $6,553,818 | Mixed | 03 Mar 2023 | ||
| Patrick G. Enright | Director | $5,538,454 | Median | 05 Aug 2026 | ||
| Mary Elizabeth Henderson | SVP, Technical Operations | $5,248,128 | -$1,418,500 | -21% | Mixed | 05 Mar 2026 |
| Kenneth W. O'Keefe | Director | $5,236,405 | Mixed | 02 Dec 2025 | ||
| Heather Ann McSharry | Director | $4,832,412 | -$1,089,127 | -18% | Median | 05 Aug 2026 |
| Norbert G. Riedel | Director | $4,640,841 | -$655,680 | -12% | Median | 05 Aug 2026 |
| Kim Sablich | EVP, GM of U.S. | $3,392,584 | Mixed | 05 Jun 2023 | ||
| Jennifer E. Cook | Director | $2,998,148 | Median | 05 Aug 2026 | ||
| Mark D. Smith | Director | $2,719,346 | -$266,746 | -8.9% | Median | 05 Aug 2026 |
| Rick E. Winningham | Director | $2,692,116 | -$1,656,872 | -38% | Median | 05 Aug 2026 |
| Finbar Larkin | SVP, Technical Operations | $2,594,532 | Mixed | 03 Mar 2023 | ||
| Laura Jean Hamill | Director | $2,057,401 | Median | 05 Aug 2026 | ||
| Patrick Kennedy | Director | $2,001,737 | Median | 05 Aug 2026 |
Recent insider transactions for Jazz Pharmaceuticals plc
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Samantha J. Pearce | JAZZ | Ordinary Shares | Tax liability | -1.63% | -780 | 47,131 | 05 Aug 2026 | Direct | ||
| Rick E. Winningham | JAZZ | Ordinary Shares | Award | 16.8% | 1,605 | 11,172 | 05 Aug 2026 | Direct | ||
| Ted W. Love | JAZZ | Ordinary Shares | Award | 105.1% | 1,605 | 3,132 | 05 Aug 2026 | Direct | ||
| Laura Jean Hamill | JAZZ | Ordinary Shares | Award | 23.2% | 1,605 | 8,538 | 05 Aug 2026 | Direct | ||
| Patrick Kennedy | JAZZ | Ordinary Shares | Award | 24% | 1,605 | 8,307 | 05 Aug 2026 | Direct | ||
| Mark D. Smith | JAZZ | Ordinary Shares | Award | 16.6% | 1,605 | 11,285 | 05 Aug 2026 | Direct | ||
| Jennifer E. Cook | JAZZ | Ordinary Shares | Award | 14.8% | 1,605 | 12,442 | 05 Aug 2026 | Direct | ||
| Seamus Mulligan | JAZZ | Ordinary Shares | Award | 0.14% | 1,605 | 1,184,633 | 05 Aug 2026 | Direct | ||
| Heather Ann McSharry | JAZZ | Ordinary Shares | Award | 8.7% | 1,605 | 20,054 | 05 Aug 2026 | Direct | ||
| Patrick G. Enright | JAZZ | Ordinary Shares | Award | 7.51% | 1,605 | 22,984 | 05 Aug 2026 | Direct | ||
| Norbert G. Riedel | JAZZ | Ordinary Shares | Award | 22.8% | 1,605 | 8,629 | 05 Aug 2026 | Direct | ||
| Bruce C. Cozadd | JAZZ | Ordinary Shares | Award | 0.44% | 1,605 | 362,287 | 05 Aug 2026 | Direct | ||
| Bruce C. Cozadd | JAZZ | Ordinary Shares | Sale | -1.64% | $1,517,880 | $252.98 | -6,000 | 360,682 | 03 Aug 2026 | Direct |
| Bruce C. Cozadd | JAZZ | Ordinary Shares | Sale | -1.61% | $1,442,820 | $240.47 | -6,000 | 366,682 | 01 Jul 2026 | Direct |
| Samantha J. Pearce | JAZZ | Ordinary Shares | Tax liability | -5.01% | -2,527 | 47,911 | 30 Jun 2026 | Direct | ||
| Renee D. Gala | JAZZ | Ordinary Shares | Tax liability | -3.18% | -4,835 | 147,361 | 30 Jun 2026 | Direct | ||
| Robert Iannone | JAZZ | Ordinary Shares | Tax liability | -4.24% | -3,764 | 85,107 | 30 Jun 2026 | Direct | ||
| Neena M. Patil | JAZZ | Ordinary Shares | Tax liability | -5.2% | -2,678 | 48,871 | 30 Jun 2026 | Direct | ||
| Philip L. Johnson | JAZZ | Ordinary Shares | Tax liability | -5.59% | -3,343 | 56,431 | 30 Jun 2026 | Direct | ||
| Mark D. Smith | JAZZ | Ordinary Shares | Sale | -10.7% | $266,746 | $230.55 | -1,157 | 9,680 | 15 Jun 2026 | Direct |
| Neena M. Patil | JAZZ | Ordinary Shares | Sale | -2.27% | $278,196 | $231.83 | -1,200 | 51,549 | 10 Jun 2026 | Direct |
| Renee D. Gala | JAZZ | Ordinary Shares | Gift | -0.39% | -600 | 152,196 | 03 Jun 2026 | Direct | ||
| Bruce C. Cozadd | JAZZ | Ordinary Shares | Sale | -1.58% | $1,410,720 | $235.12 | -6,000 | 372,682 | 01 Jun 2026 | Direct |
| Samantha J. Pearce | JAZZ | Ordinary Shares | Sale | -12.1% | $1,625,977 | $235.41 | -6,907 | 50,272 | 28 May 2026 | Direct |
| Samantha J. Pearce | JAZZ | Ordinary Shares | Options Exercise | 13.7% | 6,907 | 57,179 | 28 May 2026 | Direct | ||
| Samantha J. Pearce | JAZZ | Non-Qualified Stock Option (right to buy) | Options Exercise | -100% | -6,907 | 0 | 28 May 2026 | Direct | ||
| Seamus Mulligan | JAZZ | Ordinary Shares | Options Exercise | 0.29% | 3,415 | 1,183,028 | 28 May 2026 | Direct | ||
| Seamus Mulligan | JAZZ | Non-Qualified Stock Option (right to buy) | Options Exercise | -100% | -3,415 | 0 | 28 May 2026 | Direct | ||
| Neena M. Patil | JAZZ | Ordinary Shares | Sale | -2.21% | $282,468 | $236.97 | -1,192 | 52,626 | 28 May 2026 | Direct |
| Rick E. Winningham | JAZZ | Ordinary Shares | Sale | -22.3% | $662,143 | $241.57 | -2,741 | 9,567 | 22 May 2026 | Direct |
| Rick E. Winningham | JAZZ | Ordinary Shares | Options Exercise | 38.4% | 3,415 | 12,308 | 22 May 2026 | Direct | ||
| Rick E. Winningham | JAZZ | Non-Qualified Stock Option (right to buy) | Options Exercise | -100% | -3,415 | 0 | 22 May 2026 | Direct | ||
| Heather Ann McSharry | JAZZ | Ordinary Shares | Sale | -9.78% | $482,000 | $241.00 | -2,000 | 18,449 | 22 May 2026 | Direct |
| Bruce C. Cozadd | JAZZ | Ordinary Shares | Sale | -1.56% | $1,219,980 | $203.33 | -6,000 | 378,682 | 01 May 2026 | Direct |
| Bruce C. Cozadd | JAZZ | Ordinary Shares | Sale | -1.54% | $1,143,010 | $190.50 | -6,000 | 384,682 | 01 Apr 2026 | Direct |
| Patricia Carr | JAZZ | Ordinary Shares | Sale | -16.5% | $235,444 | $182.94 | -1,287 | 6,512 | 09 Mar 2026 | Direct |
| Bruce C. Cozadd | JAZZ | Ordinary Shares | Tax liability | -3.72% | -15,114 | 390,682 | 05 Mar 2026 | Direct | ||
| Philip L. Johnson | JAZZ | Ordinary Shares | Tax liability | -4.2% | -2,615 | 59,608 | 05 Mar 2026 | Direct | ||
| Mary Elizabeth Henderson | JAZZ | Ordinary Shares | Tax liability | -4.85% | -1,394 | 27,334 | 05 Mar 2026 | Direct | ||
| Samantha J. Pearce | JAZZ | Ordinary Shares | Tax liability | -4.74% | -2,503 | 50,272 | 05 Mar 2026 | Direct | ||
| Robert Iannone | JAZZ | Ordinary Shares | Tax liability | -6.53% | -6,209 | 88,871 | 05 Mar 2026 | Direct | ||
| Patricia Carr | JAZZ | Ordinary Shares | Tax liability | -15.6% | -1,436 | 7,799 | 05 Mar 2026 | Direct | ||
| Renee D. Gala | JAZZ | Ordinary Shares | Tax liability | -4.42% | -7,065 | 152,630 | 05 Mar 2026 | Direct | ||
| Neena M. Patil | JAZZ | Ordinary Shares | Tax liability | -8.5% | -5,000 | 53,818 | 05 Mar 2026 | Direct | ||
| Bruce C. Cozadd | JAZZ | Ordinary Shares | Sale | -1.46% | $1,118,613 | $186.44 | -6,000 | 405,796 | 03 Mar 2026 | Direct |
| Norbert G. Riedel | JAZZ | Ordinary Shares | Sale | -32.7% | $655,680 | $192.00 | -3,415 | 7,024 | 27 Feb 2026 | Direct |
| Norbert G. Riedel | JAZZ | Ordinary Shares | Options Exercise | 48.6% | 3,415 | 10,439 | 27 Feb 2026 | Direct | ||
| Norbert G. Riedel | JAZZ | Non-Qualified Stock Option (right to buy) | Options Exercise | -100% | -3,415 | 0 | 27 Feb 2026 | Direct | ||
| Patricia Carr | JAZZ | Ordinary Shares | Sale | -10.8% | $213,243 | $190.91 | -1,117 | 9,235 | 27 Feb 2026 | Direct |
| Philip L. Johnson | JAZZ | Ordinary Shares | Award | 23.5% | 11,857 | 62,223 | 26 Feb 2026 | Direct |
* marks a reported price that did not pass the local price check.